TY - JOUR
T1 - Paired immunoglobin-like receptor-B regulates the suppressive function and fate of myeloid-derived suppressor cells
AU - Ma, Ge
AU - Pan, Ping Ying
AU - Eisenstein, Samuel
AU - Divino, Celia M.
AU - Lowell, Clifford A.
AU - Takai, Toshiyuki
AU - Chen, Shu Hsia
N1 - Funding Information:
We thank M. Meseck for her kind editing of this manuscript and H.-M. Hu provided the OVA-LLC cell line. The work was supported in part by grants from the National Cancer Institute, Black Family Stem Cell Foundation, and Pfizer research fund to S.-H.C. and grant support from the Susan G. Komen Breast Cancer Foundation to P.-Y.P.
PY - 2011/3/25
Y1 - 2011/3/25
N2 - Myeloid-derived suppressor cells (MDSCs) bear characteristics of precursors for both M1 and M2 macrophages. The molecular mechanism underlying the differentiation into M1 and M2 macrophages and the relationship of this differentiation to antitumor responses remains largely undefined. Herein, we investigate the potential function of paired immunoglobulin-like receptor B (PIR-B), also known as leukocyte immunoglobulin-like receptor subfamily B member 3 (LILRB3) in MDSC differentiation, and its role in tumor-induced immunity. Our studies indicated that MDSCs genetically ablated for PIR-B (Lilrb3-/-) underwent a specific transition to M1-like cells when entering the periphery from bone marrow, resulting in decreased suppressive function, regulatory T cell activation activity, primary tumor growth, and lung metastases. Activation of Toll-like receptor (TLR), signal transducers, and activators of transcription 1 (STAT1), and nuclear factor-kappa B (NF-κB) signaling in Lilrb3-/- MDSC promoted the acquisition of M1 phenotype. Inhibition of the PIR-B signaling pathway promoted MDSC differentiation into M1 macrophages.
AB - Myeloid-derived suppressor cells (MDSCs) bear characteristics of precursors for both M1 and M2 macrophages. The molecular mechanism underlying the differentiation into M1 and M2 macrophages and the relationship of this differentiation to antitumor responses remains largely undefined. Herein, we investigate the potential function of paired immunoglobulin-like receptor B (PIR-B), also known as leukocyte immunoglobulin-like receptor subfamily B member 3 (LILRB3) in MDSC differentiation, and its role in tumor-induced immunity. Our studies indicated that MDSCs genetically ablated for PIR-B (Lilrb3-/-) underwent a specific transition to M1-like cells when entering the periphery from bone marrow, resulting in decreased suppressive function, regulatory T cell activation activity, primary tumor growth, and lung metastases. Activation of Toll-like receptor (TLR), signal transducers, and activators of transcription 1 (STAT1), and nuclear factor-kappa B (NF-κB) signaling in Lilrb3-/- MDSC promoted the acquisition of M1 phenotype. Inhibition of the PIR-B signaling pathway promoted MDSC differentiation into M1 macrophages.
UR - http://www.scopus.com/inward/record.url?scp=79952772423&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79952772423&partnerID=8YFLogxK
U2 - 10.1016/j.immuni.2011.02.004
DO - 10.1016/j.immuni.2011.02.004
M3 - Article
C2 - 21376641
AN - SCOPUS:79952772423
VL - 34
SP - 385
EP - 395
JO - Immunity
JF - Immunity
SN - 1074-7613
IS - 3
ER -